← FDA DRUG APPROVALS

FDA ANDA · ANDA075409

MIDAZOLAM HYDROCHLORIDE

Sponsor: HOSPIRA INC

APPLICATION
ANDA075409
TYPE
ANDA
ORIGINAL APPROVAL
2000-06-20
LATEST ACTION
2000-06-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MIDAZOLAM HYDROCHLORIDEDiscontinued
MIDAZOLAM HYDROCHLORIDE EQ 5MG BASE/ML · INJECTABLE · INJECTION
MIDAZOLAM HYDROCHLORIDEDiscontinued
MIDAZOLAM HYDROCHLORIDE EQ 1MG BASE/ML · INJECTABLE · INJECTION

Approval history

2000-06-20Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →